Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heptovax: GV1001 in Advanced HCC
NCT00444782Phase 2Completed
- Sponsor
- Pharmexa
- Start
- Nov 2006
- Primary completion
- Apr 2008
- Modality
- Peptides, Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
A Phase 2 trial of tertomotide in hepatocellular carcinoma (HCC), sponsored by Pharmexa. Started Nov 2006; status: completed.
02
Drugs
tertomotide
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00444782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00444782.